AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $246,667 | -58.8% | 25,829 | -57.4% | 0.00% | -60.0% |
| Q1 2021 | $598,995 | -75.0% | 60,627 | -41.5% | 0.01% | -72.2% |
| Q4 2020 | $2,392,124 | +115.5% | 103,600 | +31.8% | 0.02% | +50.0% |
| Q3 2020 | $1,110,000 | +856.9% | 78,600 | +528.9% | 0.01% | +500.0% |
| Q1 2020 | $116,000 | -95.6% | 12,498 | -95.4% | 0.00% | -90.0% |
| Q4 2019 | $2,620,000 | -18.8% | 269,000 | +4.1% | 0.02% | -13.0% |
| Q2 2019 | $3,225,000 | +2021.7% | 258,381 | +1532.5% | 0.02% | +2200.0% |
| Q4 2018 | $152,000 | -35.0% | 15,827 | +5.5% | 0.00% | 0.0% |
| Q2 2018 | $234,000 | +20.6% | 15,005 | -22.3% | 0.00% | 0.0% |
| Q2 2017 | $194,000 | -23.6% | 19,300 | -45.7% | 0.00% | -50.0% |
| Q1 2017 | $254,000 | +128.8% | 35,539 | +136.9% | 0.00% | +100.0% |
| Q3 2016 | $111,000 | -41.3% | 15,000 | -32.9% | 0.00% | 0.0% |
| Q1 2016 | $189,000 | -68.2% | 22,358 | -77.6% | 0.00% | -75.0% |
| Q3 2014 | $595,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |